A case report of gadopentetate dimeglumine-induced cardiac arrest: Resuscitation using extracorporeal membrane oxygenation

Ann Noninvasive Electrocardiol. 2023 May;28(3):e13039. doi: 10.1111/anec.13039. Epub 2023 Feb 3.

Abstract

Gadopentetate dimeglumine (Gd-DTPA) is commonly used for enhancement in magnetic resonance imaging, but rarely causes serious adverse reactions. The patient presented in this report had a cardiac arrest and multiple organ dysfunction syndrome within a short time after administration of Gd-DTPA. Immediately after receiving an intravenous injection of Gd-DTPA, the patient felt nausea and chest tightness, and developed systemic erythema. He was successfully treated using veno-arterial extracorporeal membrane oxygenation (ECMO) combined with continuous renal replacement therapy without any serious complications or neurological deficits. We report a patient who was successfully treated for Gd-DTPA-induced cardiac arrest with ECMO. Thus, ECMO may be an effective treatment for cardiac arrest secondary to anaphylaxis.

Keywords: cardiac arrest; case report; extracorporeal membrane oxygenation; gadopentetate dimeglumine.

Publication types

  • Case Reports

MeSH terms

  • Cardiopulmonary Resuscitation*
  • Electrocardiography / adverse effects
  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Extracorporeal Membrane Oxygenation* / methods
  • Gadolinium DTPA
  • Heart Arrest* / etiology
  • Heart Arrest* / therapy
  • Heart Arrest, Induced / adverse effects
  • Humans
  • Male

Substances

  • Gadolinium DTPA